New pill shows promise for hard-to-treat lung cancer in asian patients
NCT ID NCT02442349
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tested a drug called AZD9291 in 171 adults from Asia Pacific with advanced non-small cell lung cancer that had a specific gene mutation (T790M). All participants had already tried other treatments that stopped working. The goal was to see if the drug could shrink tumors and control the disease. Results showed it helped some patients, but ongoing management is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Kogarah, 2217, Australia
-
Research Site
Nedlands, 6009, Australia
-
Research Site
Woolloongabba, 4102, Australia
-
Research Site
Beijing, 100021, China
-
Research Site
Beijing, 100142, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changchun, 130000, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chongqing, 400038, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Fuzhou, 350014, China
-
Research Site
Haikou, 570311, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310006, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150049, China
-
Research Site
Jinan, 250117, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Shanghai, 200030, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shanghai, CN-200433, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhan, 430030, China
-
Research Site
Xi'an, 710032, China
-
Research Site
Xi'an, 710038, China
-
Research Site
Zhengzhou, 450008, China
-
Research Site
Goyang-si, 10408, South Korea
-
Research Site
Seongnam-si, 13620, South Korea
-
Research Site
Seoul, 05505, South Korea
-
Research Site
Seoul, 6351, South Korea
Conditions
Explore the condition pages connected to this study.